CSIMarket
 


Amarantus Bioscience Holdings, Inc.  (AMBSE)
Other Ticker:  
 

Amarantus Bioscience Holdings's Leverage Ratio

AMBSE's quarterly Leverage Ratio and Total Liabilities, Equity growth


In Spite of the repayements of liabilities of -58.17%, in I Quarter 2014 ,Leverage Ratio deteriorated to 2.23, a new company low.

Within Biotechnology & Pharmaceuticals industry in the first quarter 2014, 62 other companies have achieved lower Leverage Ratio than Amarantus Bioscience Holdings in the I Quarter 2014. While Leverage Ratio total ranking has improved so far in the first quarter 2014 to 2938, from total ranking in the forth quarter 2013 at 3409 .

Explain Leverage Ratio?
Who are AMBSE Customers?
What are AMBSE´s Total Liabilities?


AMBSE Leverage Ratio (Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter



Y / Y Equity Change - - - - -
Y / Y Total Liabilities Change - - - - -
Leverage Ratio MRQ 2.23 - - - -
AMBSE's Total Ranking # 2938 # 3409 # # #
Seq. Equity Change - - - - -
Seq. Total Liabilities Change -58.17 % - - - -



Leverage Ratio first quarter 2014 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 63
Healthcare Sector # 467
Overall Market # 2938


Leverage Ratio Statistics
High Average Low
2.23 2.23 2.23
(Mar 31 2014)  




Financial Statements
Amarantus Bioscience Holdings's Equity $ 2 Millions Visit AMBSE's Balance sheet
Amarantus Bioscience Holdings's Total Liabilities $ 3 Millions Visit AMBSE's Balance sheet
Source of AMBSE's Sales Visit AMBSE's Sales by Geography


Cumulative Amarantus Bioscience Holdings's Leverage Ratio

AMBSE's Leverage Ratio for the trailling 12 Months

AMBSE Leverage Ratio

(Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter



Y / Y Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth - - - - -
Leverage Ratio TTM - - - - -
Total Ranking TTM # 1974 # 3409 # # #
Seq. Equity TTM Growth - - - - -
Seq. Total Liabilities TTM Growth -58.17 % - - - -


On the trailing twelve months basis Due to repayements of liabilities of -58.17% Amarantus Bioscience Holdings improved Leverage Ratio in the 12 months ending in I Quarter 2014 to -1.98, below the company's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 62, during the past 12 months, other companies have achieved lower Leverage Ratio than Amarantus Bioscience Holdings. While Leverage Ratio total ranking has improved so far to 1974, from total ranking in previous 12 month period at 3409.

Explain Leverage Ratio?
Who are AMBSE Customers?
What are AMBSE´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 63
Healthcare Sector # 467
Within the Market # 1974


trailing twelve months Leverage Ratio Statistics
High Average Low
2.23 2.23 2.23
(Mar 31 2014)  




Companies with similar Leverage Ratio in the quarter ending Mar 31 2014, within Biotechnology & Pharmaceuticals Industry Leverage RatioMar 31 2014 MRQ Total LiabilitiesMar 31 2014 MRQ Equity
Exelixis Inc   5.96 $ 426.083  Millions$ 71.482  Millions
Brainstorm Cell Therapeutics inc   3.88 $ 3.333  Millions$ 0.860  Millions
Titan Pharmaceuticals Inc   2.77 $ 11.841  Millions$ 4.282  Millions
Gene Biotherapeutics Inc   2.59 $ 1.841  Millions$ 0.710  Millions
Amarantus Bioscience Holdings, Inc.  2.23 $ 3.473  Millions$ 1.559  Millions
Cel sci Corporation  1.97 $ 14.463  Millions$ 7.356  Millions
Halozyme Therapeutics Inc   1.96 $ 130.939  Millions$ 66.748  Millions
Amgen Inc   1.95 $ 44,263.000  Millions$ 22,741.000  Millions
Champions Oncology Inc   1.77 $ 5.670  Millions$ 3.197  Millions
Vericel Corporation  1.62 $ 6.109  Millions$ 3.769  Millions
Seagen Inc   1.04 $ 239.949  Millions$ 230.994  Millions
Gilead Sciences Inc   1.02 $ 14,021.753  Millions$ 13,702.194  Millions
China Biologic Products Holdings Inc   0.87 $ 222.191  Millions$ 255.992  Millions
Lineage Cell Therapeutics Inc   0.85 $ 38.707  Millions$ 45.364  Millions
Curis Inc   0.84 $ 34.201  Millions$ 40.538  Millions
Agenus Inc  0.71 $ 45.018  Millions$ 63.285  Millions
Telik Inc  0.69 $ 0.405  Millions$ 0.588  Millions
Polarityte Inc   0.68 $ 8.647  Millions$ 12.696  Millions
Qiagen N v   0.68 $ 1,804.628  Millions$ 2,657.999  Millions
Ds Healthcare Group, Inc.  0.64 $ 3.516  Millions$ 5.488  Millions
Windtree Therapeutics Inc  0.63 $ 30.691  Millions$ 48.807  Millions
Sorrento Therapeutics Inc   0.53 $ 31.465  Millions$ 59.150  Millions

Date modified: 2023-03-25T00:57:26+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com